Center for Injury Research and Policy, Abigail Wexner Research Institute at Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, 43215, USA.
Department of Pediatrics, College of Medicine, The Ohio State University, 370 W. 9th Avenue, Columbus, OH, 43210, USA.
Harm Reduct J. 2024 Oct 14;21(1):182. doi: 10.1186/s12954-024-01097-5.
The prevalence of xylazine, a non-opioid tranquilizer not for human consumption, in illicitly manufactured fentanyl is increasing in the United States. However, little is known about xylazine awareness and attitudes among people who use drugs.
A cross-sectional survey of people who use drugs in Ohio was conducted from November 2023 - May 2024 to identify xylazine awareness and attitudes in rural and urban counties across the state. Study participants were recruited from naloxone distribution sites, including health departments, syringe service programs, and community-based organizations.
Among 630 people who use drugs in Ohio, more than one-half (53.5%) were unaware of xylazine being in "street drugs," regardless of urbanicity. Among individuals who were aware of xylazine, most (73.0%) indicated they did not want to use the drug and try to avoid it. In addition, 75.8% of this group felt it was "very" or "extremely" important to know if xylazine was in their drugs.
This research found that many people who use drugs in Ohio are unaware of xylazine and its risks. An important finding of this study is that most individuals who had heard of xylazine did not want to use it and were concerned about knowing whether xylazine was in their drugs.
在美国，非阿片类镇静剂苯环己哌啶（xylazine）在非法制造的芬太尼中的流行率正在上升。然而，人们对吸毒者中苯环己哌啶的认识和态度知之甚少。
2023 年 11 月至 2024 年 5 月，在俄亥俄州进行了一项横断面调查，以确定该州农村和城市县中吸毒者对苯环己哌啶的认识和态度。研究参与者是从纳洛酮分发点招募的，包括卫生部门、注射器服务项目和社区组织。
在俄亥俄州的 630 名吸毒者中，超过一半（53.5%）的人不知道苯环己哌啶存在于“街头毒品”中，无论城市状况如何。在意识到苯环己哌啶存在的人中，大多数（73.0%）表示他们不想使用该药物并试图避免使用。此外，该组中有 75.8%的人认为知道他们的药物中是否含有苯环己哌啶“非常”或“极其”重要。
这项研究发现，俄亥俄州的许多吸毒者不知道苯环己哌啶及其风险。这项研究的一个重要发现是，大多数听说过苯环己哌啶的人都不想使用它，并担心知道他们的药物中是否含有苯环己哌啶。
